Pathstone Family Office’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$425K Buy
6,151
+538
+10% +$38.7K ﹤0.01% 1121
2023
Q2
$496K Buy
5,613
+1,268
+29% +$103K 0.01% 749
2023
Q1
$321K Sell
4,345
-8,403
-66% -$590K 0.01% 882
2022
Q4
$747K Buy
12,748
+1,976
+18% +$132K 0.01% 917
2022
Q3
$609K Buy
+10,772
New +$620K 0.01% 989

Other funds holding MMSI

Pathstone Family Office's MMSI Position: Q3 2023 in Review

Pathstone Family Office increased its Merit Medical Systems (MMSI) stake by 9.6% in Q3 2023, buying an estimated $38.7K and bringing the position to 6,151 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Pathstone Family Office first reported a position in MMSI in Q3 2022 and has held it in 5 quarters since. The position peaked at $747K in Q4 2022. 272 funds tracked by Wall St. Rank hold MMSI as of Q3 2023.

  • Pathstone Family Office held 6,151 shares of Merit Medical Systems worth $425K as of Q3 2023.
  • Pathstone Family Office bought 538 Merit Medical Systems shares in Q3 2023, an estimated $38.7K.
  • Merit Medical Systems made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1121 holding.
  • Pathstone Family Office first reported a position in Merit Medical Systems in Q3 2022 and has held it in 5 quarters since.
  • Pathstone Family Office's Merit Medical Systems position peaked at $747K in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.